PARIS, April 28 (Reuters) - French drugmaker Sanofi reported
higher-than-expected first-quarter profits on Friday, buoyed by
its specialty care division Genzyme, by vaccines, and by
consumer products acquired from Germany's Boehringer Ingelheim.
Read more
No comments:
Post a Comment